Published in Rofo on August 01, 1985
Bone scintigraphy hot-spot in projection to rib and kidney: role of single photon emission computer tomography/computer tomography in distinguishing a urine collection in renal calyx from a metastasis to rib. World J Nucl Med (2015) 0.75
Enhanced accumulation of bone seekers at superior lateral orbital margin: potential origin. World J Nucl Med (2014) 0.75
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2013) 2.27
67 Ga for tumor scanning. J Nucl Med (1972) 1.97
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging (2007) 1.72
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med (1998) 1.58
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol (1999) 1.51
The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology (1995) 1.47
The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic properties of 99m Tc labelled monoclonal antibodies in cancer patients. J Pharm Pharm Sci (2000) 1.43
Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med (1998) 1.43
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status. Eur J Nucl Med Mol Imaging (2015) 1.41
Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg (1991) 1.40
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med (1998) 1.36
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun (1989) 1.25
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg (2000) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions. Q J Nucl Med Mol Imaging (2010) 1.11
[Comparison of scintigraphy and x-ray diagnosis in osteomyelitis]. Fortschr Geb Rontgenstr Nuklearmed (1969) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Induction of CA125-specific B and T cell responses in patients injected with MAb-B43.13--evidence for antibody-mediated antigen-processing and presentation of CA125 in vivo. Cancer Biother Radiopharm (2001) 0.94
Axillary lymph node groups--the center in lymphatic drainage from the truncal skin in man. Clinical significance for management of malignant melanoma. Lymphology (1982) 0.92
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
[Combined arthroscopic and radiation synovectomy in rheumatoid arthritis]. Orthopade (1998) 0.91
Multimodal imaging of residual function and compensatory resource allocation in cortical atrophy: a case study of parietal lobe function in a patient with Huntington's disease. Psychiatry Res (1999) 0.90
[The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin (author's transl)]. Dtsch Med Wochenschr (1982) 0.90
Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med (1998) 0.88
Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer (2001) 0.88
Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Res (1997) 0.87
[Improvement in myocardial function and perfusion after recanalizing a chronic coronary artery occlusion]. Z Kardiol (1993) 0.86
New aspects of cellular thallium uptake: Tl+-Na+-2Cl(-)-cotransport is the central mechanism of ion uptake. Nuklearmedizin (1986) 0.86
Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. Int J Biol Markers (1989) 0.85
Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT. Int J Mol Imaging (2011) 0.85
Treatment of AIDS-related Kaposi's sarcoma with recombinant gamma-interferon. Onkologie (1986) 0.85
Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen. Nucl Med Commun (1998) 0.84
Current treatment options for neuroendocrine tumors. Drugs Today (Barc) (2011) 0.84
[Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment]. Pathologe (2005) 0.83
[Blood pool scintigraphy with short-lived radioisotopes]. Fortschr Geb Rontgenstr Nuklearmed (1970) 0.83
Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after. J Nucl Biol Med (1992) 0.83
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial. Med Pediatr Oncol (1991) 0.83
Radionuclides in renal transplantation. J Nucl Med (1972) 0.82
Evaluation of the effects of total sleep deprivation on cerebral blood flow using single photon emission computerized tomography. Acta Psychiatr Scand (1992) 0.82
Tumor markers, liver function tests and symptoms in 115 patients with isolated colorectal liver metastases. Int J Biol Markers (1989) 0.82
Diagnostic accuracy and predictive value of the tumor-associated antigen S100 in malignant melanomas: validation by whole body FDG-PET and conventional diagnostics. Anticancer Res (1999) 0.81
Morphological and functional findings of fixed phagocytes in psoriatics. Arch Dermatol Res (1983) 0.81
[Scintigraphy of tumors in the head and neck area]. DDZ (1971) 0.81
Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med (2000) 0.81
[Function tests in nephroptoses by means of the o-131iod hippuran nephrography]. Fortschr Geb Rontgenstr Nuklearmed (1971) 0.81
Congenital microgastria, growth hormone deficiency and diabetes insipidus. Eur J Pediatr (1997) 0.81
In vivo behaviour of homologous urea-soluble 131I-fibrin and 125I-fibrinogen in rabbits: the effect of fibrinolysis inhibition. Br J Haematol (1976) 0.80
Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1). Cancer Immunol Immunother (1998) 0.80
Late results of heterotopic autotransplantation of splenic tissue into the greater omentum. World J Surg (1998) 0.80
Functional studies of sessile macrophages in liver and spleen of psoriatics. Dermatologica (1983) 0.80
Direct labeling of monoclonal antibodies with technetium-99m by photoactivation. J Nucl Med (1995) 0.80
131-Metaiodobenzylguanedine therapy of neuroblastoma in childhood. One year of therapeutic experience. Eur J Pediatr (1987) 0.80
Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13. Hybridoma (1993) 0.80
Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients. Nucl Med Commun (1997) 0.79
[Scintigraphic and experimental studies with 67Ga in 142 patients with bronchial cancer (author's transl)]. Nuklearmedizin (1978) 0.79
Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor. J Nucl Med (1995) 0.79
Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography. Eur J Nucl Med (1993) 0.79
Experience with 201 thallium in detection of myocardial infarction. Eur J Nucl Med (1976) 0.79
Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection. Nuklearmedizin (1998) 0.79
Gated metabolic positron emission tomography (GAPET) of the myocardium: 18F-FDG-PET to optimize recognition of myocardial hibernation. Nucl Med Commun (1998) 0.78
Early diagnosis of cardiac involvement in systemic sclerosis by 123I-MIBG neurotransmitter scintigraphy. Nucl Med Commun (1998) 0.78
Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26. Br J Cancer Suppl (1990) 0.78
Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation. J Nucl Med (1996) 0.78
Vandetanib therapy in medullary thyroid cancer. Drugs Today (Barc) (2012) 0.78
[47-year-old patient with pulmonary hypertension, anemia and thrombocytopenia]. Internist (Berl) (1995) 0.78
Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis? Int J Card Imaging (1990) 0.78
Changing patterns of patients undergoing emergency surgical revascularization for acute coronary occlusion. Importance of myocardial protection techniques. J Thorac Cardiovasc Surg (1993) 0.78
Experimental studies on lymphatic drainage of the peritoneal cavity using 198Au-colloid. Lymphology (1973) 0.78
[Radiophosphorus therapy of polycythemia vera]. Ther Umsch (1973) 0.78
Noninvasive assessment of left ventricular performance following transluminal coronary angioplasty. Int J Cardiol (1983) 0.78
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]. Pneumologie (2012) 0.78
Prognostic significance of coronary flow reserve on left ventricular ejection fraction in cardiac transplant recipients. Transplantation (1998) 0.78
Fully automated sectorial equilibrium radionuclide ventriculography. Proposal of a method for routine use: exercise and follow-up. Eur J Nucl Med (1983) 0.77
Therapeutic nuclear medicine in pediatric malignancy. Q J Nucl Med Mol Imaging (2010) 0.77
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Leuk Lymphoma (1999) 0.77
Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia. Psychiatry Res (1994) 0.77
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registry. Recent Results Cancer Res (2013) 0.77